Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10298689 | European Neuropsychopharmacology | 2014 | 12 Pages |
Abstract
Taken together, one-year treatment with stimulants or atomoxetine was associated with a clinically significant reduction in ADHD symptoms and mental distress, and improvement of measured function. No serious adverse events were observed.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Mats Fredriksen, Alv A. Dahl, Egil W. Martinsen, Ole Klungsøyr, Jan Haavik, Dawn E. Peleikis,